Want to join the conversation?
$ESRX expects 3Q16 adjusted EPS of $1.72-1.76, which represents a 19-21% YoverY growth, and total adjusted claims of 311-321MM. The company is increasing its expected 2017 retention rate for the 2016 selling season to range of 96-98%, excluding impact of remaining Coventry business rolling off in 2017, representing about 1% of claims.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?